← Back
Data updated: Mar 29, 2026
ASSERTIO SPECLTY
Neurology
Specialty
ASSERTIO SPECLTY is a specialty pharmaceutical company focused on Neurology. Key products include SYMPAZAN.
2009
Since
4
Drugs
-
Trials
2
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Discontinued (2)
Company Info
- First Approval
- 2009-06-17
- Latest
- 2024-11-21
- Applications
- 3